Osteoarthritis is a prevalent condition that significantly impacts the economy. The overall economic burden in the US is estimated at almost $140 billion annually. This includes healthcare costs, lost personal income, and reduced work capacity due to arthritis.
Synvisc One is a viscosupplementation treatment designed to alleviate knee pain caused by osteoarthritis. It involves injecting hyaluronic acid into the knee joint to improve lubrication and cushioning, providing up to six months of pain relief.
Medical practices looking to buy Synvisc online should source the product through authorized suppliers to help ensure authenticity, appropriate storage, and proper handling.
In this article, we will explore the Synvisc One pros and cons, examining its benefits, potential drawbacks, and what patients can expect from this treatment.
Key Takeaways
- Synvisc One is a single-injection treatment designed to relieve knee pain caused by osteoarthritis. It replenishes the joint’s natural fluid, reducing friction and improving joint function for up to six months.
- The pros of Synvisc One include its ability to provide long-lasting pain relief, the convenience of one injection, and the potential to delay the need for surgery.
- The cons of this treatment include possible side effects such as knee pain, swelling, or stiffness, as well as cost concerns, as not all insurance plans may cover the treatment.
- Effectiveness varies from patient to patient, meaning some may experience significant relief while others may see minimal improvement.
About: Doctor Medica is your trusted supplier of top-quality dermal fillers, viscosupplements, and more for your medical practice. We offer genuine products from leading brands at the lowest prices in the market.
Recommended products
Synvisc One Pros and Cons: Treatment Overview

Synvisc One is a single-injection treatment designed to relieve knee pain caused by osteoarthritis. It contains hyaluronic acid, a substance naturally found in the body’s joints that helps lubricate and cushion them. In patients with osteoarthritis, this natural fluid breaks down, leading to joint pain and stiffness. Synvisc One replenishes the joint’s lubrication, making movement smoother and less painful.
The mechanism of action involves increasing the joint’s synovial fluid, which reduces friction between bones and acts as a shock absorber during movement. This minimally invasive treatment is an option for individuals who haven’t experienced relief from other therapies, such as pain medications or physical therapy.
Targeted specifically for osteoarthritis pain, Synvisc One offers up to six months of pain relief and improved joint function, helping patients regain mobility and reduce discomfort in their daily activities.
The Pros of Synvisc One for Osteoarthritis Treatment

When reviewing the Synvisc One pros and cons, one of the main advantages is the convenience of a single injection combined with the potential for several months of symptom relief.
- Long-lasting Pain Relief: Synvisc One can relieve pain for up to six months [1]. This extended period of comfort allows individuals with osteoarthritis to experience reduced discomfort and improved joint function. Synvisc injections supplement the joint’s natural fluid to help it move smoothly and with less pain.
- Single Injection Convenience: Unlike other treatments that require multiple visits, Synvisc One is administered in just one session, saving time and sparing patients from repeated needle pricks.
- Potential Delay of Surgery: For patients with severe knee osteoarthritis, the Synvisc injection may help delay the need for surgery. Adding cushioning and improving the knee’s fluid levels can enhance joint function and reduce pain, potentially postponing more invasive interventions like knee replacement surgery.
The Cons of Synvisc One for Osteoarthritis Treatment

The Synvisc One pros and cons should also be considered in relation to potential side effects, treatment costs, and differences in individual response.
- Potential Side Effects: Commonly reported issues with Synvisc One include knee pain, stiffness, and swelling or fluid buildup in or around the knee [2]. Though these side effects are generally mild and resolve over time, they can cause discomfort. In rare cases, more serious complications, such as infections or allergic reactions, may occur.
- Cost Considerations: These treatments can be expensive, and while some insurance plans may cover them, others might not. Without insurance coverage, the out-of-pocket expenses for each injection could be a barrier for those seeking long-term relief from knee osteoarthritis.
- Variable Effectiveness for Different Individuals: While some patients experience significant pain relief and improved mobility, others may notice little to no change in their symptoms. The treatment’s effectiveness varies depending on the individual’s condition and how their body responds to the injection.
Conclusion
Understanding the Synvisc One pros and cons can help patients and healthcare providers evaluate whether this minimally invasive option is appropriate for managing knee osteoarthritis pain. Its potential for long-lasting effects and improved joint function makes it a consideration for those who have not found adequate relief with other treatments.
However, discussing the potential benefits and risks with a healthcare provider is essential to determine if it’s the right option for your specific condition.
FAQs
1. What is Synvisc One?
Synvisc One is a single-injection viscosupplement designed to treat knee osteoarthritis. It provides lubrication and cushioning in the joint to reduce pain and improve mobility.
2. How long does the pain relief from Synvisc-One last?
A single injection can provide pain relief for up to six months, though individual results may vary.
3. Is Synvisc One covered by insurance?
Insurance coverage varies; it’s advisable to consult your healthcare provider and insurance company to understand your specific coverage and potential out-of-pocket costs.
4. Can Synvisc One be used for other joints besides the knee?
Synvisc One is primarily approved for treating knee osteoarthritis. Use in other joints should be discussed with a healthcare provider to determine appropriateness.
Citations
[1] Bernstein, Susan. “Hyalgan vs. Synvisc: Differences and Similarities.” WebMD, medically reviewed by David Zelman, 26 Aug. 2024, https://www.webmd.com/osteoarthritis/osteoarthritis-hyalgan-synvisc.
[2] Sanofi. “SYNVISC® (Hylan G-F 20) Clinical Efficacy, Safety, and Study Design.” Sanofi Campus, n.d., https://pro.campus.sanofi/us/products/synviscone/synvisc.
[3] Osteoarthritis Action Alliance. “OA Prevalence and Burden.” Osteoarthritis Action Alliance, 31 May 2024, https://oaaction.unc.edu/oa-module/oa-prevalence-and-burden/.
[4] Pereira, Tiago V., et al. “Viscosupplementation for Knee Osteoarthritis: Systematic Review and Meta-Analysis.” BMJ, vol. 378, 2022, article e069722. https://doi.org/10.1136/bmj-2022-069722.
[5] RxList. “Synvisc (Hylan G-F 20): Side Effects, Uses, Dosage, Interactions, Warnings.” RxList, updated 14 June 2022, https://www.rxlist.com/synvisc-drug.htm.
The content on this page has been written and fact-checked in accordance with our Editorial Policy. Clinical claims are sourced from peer-reviewed literature, regulatory documentation, and manufacturer specifications. Where citations are provided, it is always in accordance to our editorial standards.